U.S. Markets open in 5 hrs 40 mins

NeuroPace, Inc. (NPCE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
21.52-0.49 (-2.23%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close22.01
Open22.16
Bid0.00 x 800
Ask0.00 x 1300
Day's Range20.81 - 22.35
52 Week Range18.24 - 27.38
Volume29,388
Avg. Volume117,634
Market Cap522.744M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Have Insiders Been Buying NeuroPace, Inc. (NASDAQ:NPCE) Shares?
    Simply Wall St.

    Have Insiders Been Buying NeuroPace, Inc. (NASDAQ:NPCE) Shares?

    We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...

  • Could This Recently IPOed Medical Device Maker Make You Rich?
    Motley Fool

    Could This Recently IPOed Medical Device Maker Make You Rich?

    NeuroPace (NASDAQ: NPCE), is growing the implantable device market for treating drug-resistant focal epilepsy and setting itself up to dominate it for years to come. With an offering that provides better outcomes than its competition, significant penetration into epilepsy centers across the U.S., and potential label expansions that could just about double its current addressable market, this company could offer significant upside to investors. NeuroPace makes a $50,000 implantable device, the RNS (Responsive Neurostimulation) System, that continuously monitors epilepsy patients' brain activity and responds to patient-specific seizure patterns.